Medicine and Dentistry
Vasculotropin
100%
Antiangiogenic Activity
100%
Vasculotropin Receptor
100%
Angiogenesis
83%
Antiangiogenic
50%
Vascular Endothelial Cell
33%
In Vitro
16%
Malignant Neoplasm
16%
Neoplasm
16%
Therapeutic Agent
16%
Tumor Cell
16%
Wound Healing
16%
Ex Vivo
16%
down Regulation
16%
Phosphotransferase
16%
Tissue Growth
16%
Tumor Progression
16%
Microvessel
16%
Matrigel
16%
Xenograft
16%
Cancer Treatment
16%
Growth, Development and Aging
16%
Vasculotropin Receptor 2
16%
Tumor Angiogenesis
16%
Focal Adhesion Kinase
16%
Kinase Assay
16%
Angiogenesis Model
16%
Phosphoinositide Dependent Protein Kinase 1
16%
Benzimidazole Derivative
16%
Mitogen-Activated Protein Kinase
16%
Protein Kinases
16%
Biochemistry, Genetics and Molecular Biology
Antiangiogenic Activity
100%
Angiogenesis
100%
VEGF Receptors
100%
Vascular Endothelial Growth Factor
100%
Kinase
33%
Phosphotransferase
33%
Wound Healing
16%
down Regulation
16%
Extracellular Signal-Regulated Kinases
16%
Anticancer
16%
Neovascularization (Pathology)
16%
Growth, Development and Aging
16%
Tissue Growth
16%
Tumor Progression
16%
Protein Kinases
16%
Phosphoinositide-Dependent Kinase-1
16%
Janus Kinase 1
16%
Kinase Insert Domain Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Antiangiogenic
100%
Vasculotropin Receptor
100%
Neoplasm
50%
Phosphotransferase
33%
Malignant Neoplasm
16%
Neovascularization (Pathology)
16%
Wound Healing
16%
Mitogen Activated Protein Kinase
16%
Matrigel
16%
Tumor Growth
16%
Focal Adhesion Kinase
16%
Vasculotropin Receptor 2
16%
Benzimidazole Derivative
16%
Phosphoinositide Dependent Protein Kinase 1
16%
Protein Kinases
16%